Femasys Stock Forum

$Femasys (FEMY.US)$ Reuters· 1 min ago
Femasys Announces Partnership With Boston IVF, Prominent Network of Fertility Centers, to Offer Femaseed

$Femasys (FEMY.US)$
Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces that the Company has received its second order from its strategic distribut...

$Femasys (FEMY.US)$ Reuters
·3 mins ago
Femasys Secures Strategic Distribution Partnerships for Commercialization of Femaseed® for Over $1.3M in Spanish Market

$Femasys (FEMY.US)$
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
Share on Reddit
Share on Facebook
09/11/2024 - 05:30 AM
Company taps Comercial Medico Quirurigca, SA and Durgalab as first EU distributors for its CE-marked women’s reproductive healthcare products
ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of wome...

$Femasys (FEMY.US)$  with good news and went red.  ?  🥴

$Femasys (FEMY.US)$
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
ATLANTA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, today announced it has received 510(k) clearance from the United States Food and Drug Ad...

$Femasys (FEMY.US)$ Femasys Announces Ce Mark and Canadian Approval for Femvue® Mini, a Fallopian Tube Assessment Solution

$Femasys (FEMY.US)$ 8k report: On June 20, 2024, Femasys Inc., a biomedical company specializing in women's health, announced the receipt of CE Mark approval for four of its products, enabling the start of commercialization efforts in Europe. The approved products, which include FemaSeed, FemVue, FemCerv, and FemCath, comply with the European Union Medical Device Regulation (EU MDR). This regulatory milestone follows the company's recent completion of its commercial team in the United States and ...

$Femasys (FEMY.US)$ Great results for their drugs. European approval. Great buy at this price!
他们的药欧洲给过，趁便宜快买!

$Femasys (FEMY.US)$ Really nice push on such low volume